Summary
Updated Aug 30, 2026
David Hallal files SEC Form 4 reports at Kalaris Therapeutics, Inc. (KLRS). 6 SEC Form 4 filings on record going back to 2025, most recently on 4 June 2026. Most recent open-market trade: sold $1.52M of SRRK on 20 April 2026. Lifetime open-market sales: $3.97M.
Recent Transactions
4Every recent SEC Form 4 transaction David Hallal has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies David Hallal files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Srinivas Akkaraju - $6.18M of KLRS open-market activity in the last 12 months
- Brett R. Hagen - $13K of KLRS open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is David Hallal?
David Hallal is a corporate insider of Kalaris Therapeutics, Inc. (KLRS). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has David Hallal submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.
Has David Hallal been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($3.97M) across all tracked filings.
Where can I see all of David Hallal's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow David Hallal and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
